肺气肿与COPD肺外组织丢失:多器官组织丢失表型
在ECLIPSE COPD队列1817例患者中,按定量CT肺气肿四分位分组比较临床与全身生物标志物,并分析LAA%与3年FEV1、BMI、FFMI下降及急性加重、住院和死亡率的关系。肺气肿更重者基线FEV1、BMI、FFMI更低,功能容量更差,FEV1、BMI、FFMI下降更快,急性加重、住院和死亡率更高,提出多器官组织丢失(MOLT)COPD表型。
要点
- 肺气肿更重的COPD患者基线FEV1、BMI、FFMI更低且功能容量更差。
- 肺气肿更重者FEV1、BMI、FFMI下降更快,急性加重、住院和死亡率更高。
- 建议将此类COPD亚组命名为多器官组织丢失(MOLT)表型。
核心结论
- 肺气肿更重的COPD患者存在肺及肺外组织过度丢失,可能与组织维持异常相关。
- 因临床结局更差,建议将该亚组命名为多器官组织丢失(MOLT)COPD表型。
研究设计与样本
- 研究纳入ECLIPSE COPD队列1817例患者,按定量CT肺气肿四分位(LAA%)分组比较临床与部分全身生物标志物。
- 对最低和最高肺气肿四分位患者进行氨基酸代谢组学分析,并分析LAA%与3年FEV1、BMI、FFMI下降及急性加重、住院和死亡率的关系。
主要发现
- 基线肺气肿更重者FEV1、BMI、FFMI更低,功能容量更差,心血管疾病更少但骨质疏松更多。
- 各组全身C反应蛋白和白细胞介素-6水平相似,肺气肿更重者Clara细胞蛋白16更高,白细胞介素-8、表面活性蛋白D和可溶性晚期糖基化终产物受体更低。
- 极端肺气肿四分位间代谢组学存在差异。
- 肺气肿更重者FEV1、BMI和FFMI下降更快,急性加重、住院和死亡率更高。
临床怎么用
- 对COPD患者评估肺气肿程度时,应关注BMI、FFMI等肺外组织指标及急性加重、住院和死亡风险。
- 肺气肿更重且伴FEV1、BMI、FFMI下降更快者,可考虑归为MOLT表型以加强随访和综合管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We tested whether emphysema progression accompanies enhanced tissue loss in other body compartments in 1817 patients from the ECLIPSE chronic obstructive pulmonary disease (COPD) cohort.Clinical and selected systemic biomarker measurements were compared in subjects grouped by quantitative tomography scan emphysema quartiles using the percentage of low attenuation area (LAA%). Lowest and highest quartile patients had amino-acid metabolomic profiles. We related LAA% to 3 years decline in lung function (forced expiratory volume in 1 s (FEV1)), body mass index (BMI), fat-free mass index (FFMI) and exacerbations, hospitalisations and mortality rates.Participants with more baseline emphysema had lower FEV1, BMI and FFMI, worse functional capacity, and less cardiovascular disease but more osteoporosis. Systemic C-reactive protein and interleukin-6 levels were similar among groups, but club cell protein 16 was higher and interleukin-8, surfactant protein D and soluble receptor for advanced glycation end product were lower with more emphysema. Metabolomics differed between extreme emphysema quartiles. Patients with more emphysema had accelerated FEV1, BMI and FFMI decline and more exacerbations, hospitalisations and mortality.COPD patients with more emphysema undergo excessive loss of pulmonary and extrapulmonary tissue, which is probably related to abnormal tissue maintenance. Because of worse clinical outcomes, we propose this subgroup be named the multi-organ loss of tissue (MOLT) COPD phenotype.
引用
- Celli BR, Locantore N, Tal-Singer R, et al. Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype. Eur Respir J. 2018. PMID: 29437944. doi:10.1183/13993003.02146-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。